PFOCUS NSE filing

Prime Focus: Monitoring Agency Report for Q4FY26 Shows No Deviation in Fund Utilization

The RealCase readLow impact Neutral

Prime Focus Limited's Monitoring Agency Report for Q4FY26 confirms no deviation in the utilization of ₹5,552.02 crore raised via preferential issue. No funds were utilized in the quarter, with unutilized proceeds of ₹215.10 crore parked in liquid mutual funds. The company reported a net profit of ₹183.72 crore for 9M FY26.

Why it matters

This is a routine quarterly compliance report. It confirms the utilization of funds as per the plan, which is expected by investors and regulators. There are no new material developments or significant deviations that would significantly impact the company's stock or business operations.

The market read

The report is a routine monitoring agency submission confirming no deviations in fund utilization, which is a standard compliance activity. While the company reported a profit in 9M FY26, the lack of fund utilization in the current quarter and the significant unutilized amount maintain a neutral sentiment.

Prime Focus Limited has submitted its Monitoring Agency Report for the quarter ended March 31, 2026, as required by SEBI regulations. The report, issued by CARE Ratings Limited, confirms that there have been no deviations from the stated objects for the utilization of funds raised through a Preferential Issue of Equity Shares amounting to ₹5,552.02 crore. The company reported nil utilization of funds in Q4FY26, with the unutilized proceeds parked in liquid mutual funds. There were numerous transactions involving redemption and investment of mutual funds during the quarter, leading to a commingling of funds. Consequently, the Monitoring Agency relied on the management certificate and closing balances of mutual fund statements for classification.

The report details the progress of various objects, including the acquisition of shares in DNEG S.a.r.l., investment in a wholly-owned subsidiary, expansion of business operations, and general corporate purposes. While the original cost for the acquisition of shares in DNEG S.a.r.l. was ₹5,161.50 crore, no utilization occurred in Q4FY26, leaving the entire amount unutilized. Similarly, investments in subsidiaries and business expansion projects also show nil utilization for the quarter. General corporate purposes had an original cost of ₹97.63 crore, with ₹0.02 crore utilized during the quarter, leaving ₹97.61 crore unutilized.

The total unutilized proceeds as of March 31, 2026, amounted to ₹215.10 crore, primarily invested in liquid and arbitrage funds. The report also addresses the timelines for object implementation, noting that the acquisition of shares in DNEG S.a.r.l. has no specified completion date in the PAS-4 document. Other objects have timelines ranging from within 6 to 18 months from the receipt of funds, with ongoing progress reported. The company's financial performance for FY24 and FY25 showed net losses, but a net profit of ₹183.72 crore was reported for 9M FY26 at the consolidated level, while the standalone level reported a net loss of ₹7.07 crore for 9M FY26.

Filing to action

What to do with a filing like this

Prime Focus Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Prime Focus Limited. Read the original for the full detail.

View original filing